Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence

Evidence-based guidelines have been developed outlining the concomitant use of anti-tumor necrosis factor alpha (anti-TNF) agents and immunomodulators including azathioprine (AZA) and methotrexate (MTX) in both adult and pediatric populations. However, there exists a paucity of data guiding evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Meredith, Joseph, Henderson, Paul, Wilson, David C., Russell, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490777/
https://www.ncbi.nlm.nih.gov/pubmed/34621712
http://dx.doi.org/10.3389/fped.2021.708310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490777/
https://www.ncbi.nlm.nih.gov/pubmed/34621712
http://dx.doi.org/10.3389/fped.2021.708310

Ejemplares similares